ATE462140T1 - Verfahren zum nachweis aggregatbildender zirkulierender proteinformen und mittel zum einfangen gebildeter aggregate - Google Patents

Verfahren zum nachweis aggregatbildender zirkulierender proteinformen und mittel zum einfangen gebildeter aggregate

Info

Publication number
ATE462140T1
ATE462140T1 AT06778816T AT06778816T ATE462140T1 AT E462140 T1 ATE462140 T1 AT E462140T1 AT 06778816 T AT06778816 T AT 06778816T AT 06778816 T AT06778816 T AT 06778816T AT E462140 T1 ATE462140 T1 AT E462140T1
Authority
AT
Austria
Prior art keywords
forming
aggregate
protein forms
circulative
catching
Prior art date
Application number
AT06778816T
Other languages
English (en)
Inventor
Anne Eveno-Nobile
Anthony Coleman
Sebastien Cecillon
Herve Perron
Marc Rodrigue
Original Assignee
Centre Nat Rech Scient
Biomerieux Sa
Univ Claude Bernard Lyon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient, Biomerieux Sa, Univ Claude Bernard Lyon filed Critical Centre Nat Rech Scient
Application granted granted Critical
Publication of ATE462140T1 publication Critical patent/ATE462140T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4709—Amyloid plaque core protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2835—Movement disorders, e.g. Parkinson, Huntington, Tourette

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
AT06778816T 2005-07-21 2006-07-07 Verfahren zum nachweis aggregatbildender zirkulierender proteinformen und mittel zum einfangen gebildeter aggregate ATE462140T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0507757A FR2888937B1 (fr) 2005-07-21 2005-07-21 Procede de detection des fcpa utilisant un agent d'agregation des fcpa et un agent de capture des agregats formes
PCT/FR2006/001641 WO2007010110A2 (fr) 2005-07-21 2006-07-07 Procede de detection des fpca utilisant un agent d'agregation des fpca et un agent de capture des agregats formes

Publications (1)

Publication Number Publication Date
ATE462140T1 true ATE462140T1 (de) 2010-04-15

Family

ID=36011928

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06778816T ATE462140T1 (de) 2005-07-21 2006-07-07 Verfahren zum nachweis aggregatbildender zirkulierender proteinformen und mittel zum einfangen gebildeter aggregate

Country Status (8)

Country Link
US (1) US8158441B2 (de)
EP (1) EP1907861B1 (de)
JP (2) JP5693816B2 (de)
AT (1) ATE462140T1 (de)
DE (1) DE602006013143D1 (de)
ES (1) ES2343474T3 (de)
FR (1) FR2888937B1 (de)
WO (1) WO2007010110A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2931695B1 (fr) * 2008-05-28 2010-06-25 Centre Nat Rech Scient Procede d'extraction selective de proteines membranaires avec les calixarenes
JP5732292B2 (ja) * 2011-03-28 2015-06-10 日東電工株式会社 スルホン酸基含有ジアミン化合物とその製造方法
WO2013091074A1 (en) * 2011-12-21 2013-06-27 Uvic Industry Partnerships Inc. Method and array for identifying histone-code-related analytes
KR101658620B1 (ko) * 2014-12-02 2016-09-23 주식회사 피플바이오 응집형-형성 폴리펩타이드의 응집형을 검출하는 방법
US10338037B2 (en) 2015-08-18 2019-07-02 Uvic Industry Partnerships Inc. Compounds and conjugates for identifying and separating post-translationally modified analytes
EP3383381B1 (de) * 2015-11-30 2020-04-08 Universität Wien Zusammensetzung zur verwendung bei der vorbeugung und behandlung neurodegenerativer erkrankungen
EP3207925A1 (de) * 2016-02-22 2017-08-23 Universität Wien Zusammensetzung zur verwendung bei der vorbeugung und behandlung neurodegenerativer erkrankungen
EP3600027A4 (de) * 2017-03-31 2020-12-23 Neurodiagnostics LLC Auf lymphozyten basierender morphometrischer test auf morbus alzheimer
US11629128B2 (en) 2019-06-25 2023-04-18 Uvic Industry Partnerships Inc. Compound and dimer complex embodiments for supramolecular sensing
CN111517947B (zh) * 2020-03-18 2022-05-24 西北师范大学 一种基于功能化的双边柱[5]芳烃传感器分子及其合成和应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6365414B1 (en) * 1994-08-26 2002-04-02 The General Hospital Corporation Vitro system for determining formation of Aβ amyloid
US5639626A (en) 1994-11-15 1997-06-17 Chiron Diagnostics Corporation Reagents for specific binding assays
WO1997041856A1 (en) 1996-05-08 1997-11-13 Massachusetts Institute Of Technology ORGANOMETALLIC LIGANDS FOR THE LOCALIZATION AND QUANTIFICATION OF AMYLOID IN VIVO AND $i(IN VITRO)
GB9610829D0 (en) * 1996-05-23 1996-07-31 Medical Res Council Screening of agents for treatment of azlheimers disease
CA2301142A1 (en) * 1997-08-14 1999-02-25 The Regents Of The University Of California Fluorescent amyloid a.beta. peptides and uses thereof
PE129999A1 (es) 1997-10-30 1999-12-30 Shell Int Research Hidrolisis catalitica de oxidos de alquileno
GB9908059D0 (en) 1999-04-09 1999-06-02 Imp College Innovations Ltd Diagnosis and treatment of diseases
AU2002241909A1 (en) 2001-01-19 2002-07-30 Baxter Healthcare S.A. Method of detecting prp protein and kits therefor
DE10107083C2 (de) 2001-02-13 2003-02-20 Abdulgabar Salama Pentosan Polysulfat als Ligand zum Nachweis von Prionen
DE10119713A1 (de) 2001-04-21 2002-10-24 Prionics Ag Zuerich Verfahren zur Untersuchung von Prion-Protein enthaltenden Proben auf das eventuelle Vorliegen der PrPSc-Form
RU2309410C2 (ru) * 2002-02-28 2007-10-27 Майкроусенс Байофейдж Лимитед Связывание патологических форм прионовых белков
JP4469281B2 (ja) * 2002-11-01 2010-05-26 プロテオテック・インコーポレーテッド 硫酸化グリコサミノグリカンによる、アルツハイマー病アミロイド斑形成の迅速な誘導
FR2849204B1 (fr) 2002-12-20 2005-02-11 Afssa Procede de detection de la prpsc utilisant un antibiotique d de la famille des aminoglycosides pour l'elimination et la detection de la prpsc dans des echantillons biologiques
FR2849205B1 (fr) 2002-12-20 2005-02-11 Afssa Procede d'amplification de la detection de la prpsc et utilisation d'un ligand adjuvant macrocyclique pour une telle amplification
IL158010A0 (en) 2003-09-18 2004-03-28 Hadasit Med Res Service Methods and kits for the detection of prion diseases
FR2865280B1 (fr) * 2004-01-20 2007-01-12 Biomerieux Sa Procede de detection de la prp utilisant une molecule ayant au moins une charge positive et/ou au moins une liaison osidique et un ligand autre qu'un ligand proteique

Also Published As

Publication number Publication date
JP5785642B2 (ja) 2015-09-30
DE602006013143D1 (de) 2010-05-06
WO2007010110A2 (fr) 2007-01-25
EP1907861A2 (de) 2008-04-09
US20100062540A1 (en) 2010-03-11
JP2014178337A (ja) 2014-09-25
JP5693816B2 (ja) 2015-04-01
US8158441B2 (en) 2012-04-17
WO2007010110A3 (fr) 2007-04-05
ES2343474T3 (es) 2010-08-02
FR2888937A1 (fr) 2007-01-26
JP2009501922A (ja) 2009-01-22
EP1907861B1 (de) 2010-03-24
FR2888937B1 (fr) 2012-10-26

Similar Documents

Publication Publication Date Title
ATE462140T1 (de) Verfahren zum nachweis aggregatbildender zirkulierender proteinformen und mittel zum einfangen gebildeter aggregate
NO20072721L (no) Polypeptides that bind BR3 and uses thereof
DE602004006894D1 (de) Vorrichtung zur klassifizierung von sitzbelegung
DE602006007808D1 (de) Vorrichtung, verfahren und verwendung zur behandlung von neuropathie mit stickoxid
ATE496905T1 (de) Triazolyl-pyridyl-benzolsulfonamide als ccr2- oder ccr9-modulatoren zur behandlung von atherosklerose
DE602005008970D1 (de) Verfahren und zusammensetzungen zur behandlung von augenerkrankungen mit retinyl-derivaten
DE602005011656D1 (de) Verfahren zur behandlung von dickdarmkrebs mit botulinum neurotoxin
ATE472327T1 (de) Ä4-(heteroaryl)piperazin-1-ylü-(2,5-substituier e phenyl)methanon-derivate als glycin-transporter 1 (glyt-1) hemmer zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
DE602006002541D1 (de) Kommunikationsgerät, Kommunikationssystem, und Verfahren zur Einstellung von Kommunikationsparametern des Kommunikationsgeräts
ATE528649T1 (de) Verfahren zum nachweis falsch gefalteter proteine und prionen
DE602006008581D1 (de) Verfahren zur bestimmung von montagebedingungen, vorrichtung zur bestimmung von montagebedingungen und montagevorrichtung
EA201590630A1 (ru) Способы лечения и диагностики, связанные с лизилоксидазоподобным белком 2 (loxl2)
DE602006004529D1 (de) Verfahren und Vorrichtung zur Kontrolle von Objekten
ATE549416T1 (de) Verfahren und zusammensetzungen zum nachweis von autoimmunkrankheiten
EA200702193A1 (ru) Гликозилирование белков
ATE454473T1 (de) Verfahren zur bestimmung der dna-fragmentierung in spermienzellen von tieren
ATE410166T1 (de) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin- derivate zur behandlung von unfruchtbarkeit
DE602005013650D1 (de) Proteinhydrolysat zur behandlung von müdigkeit
DE602004018249D1 (de) Verfahren zur Dearomatisierung von Molkeprotein
DE602006007421D1 (de) Verfahren und Vorrichtung zur Detektion von Kolloid
DE602007001435D1 (de) Vorrichtung zur Reinigung und Behandlung von Rinderhufen
ATE547161T1 (de) Verfahren zur quantitativen bestimmung von poloxameren
DE502006007919D1 (de) Verfahren und vorrichtung zum festwalzen von kurbelwellen
ATE425269T1 (de) Zusammensetzung zur behandlung von leder
ATE380255T1 (de) Verfahren zur behandlung von tierhäuten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties